Long-acting reversible contraception, such as hormonal and non-hormonal intrauterine devices (IUDs) and hormonal implants, have been proven safe and effective for adolescent patients.
Twirla (levonorgestrel and ethinyl estradiol) transdermal system is now available as a method of contraception for use in women of reproductive potential with a BMI <30kg/m2 for whom a combined hormonal contraceptive is appropriate.
Many transgender people receiving gender-affirming hormone therapy have cardiovascular disease risk factors, and a considerable proportion are not receiving appropriate therapies.
Gemmily contains 24 active capsules containing 1mg of norethindrone acetate and 20mcg of ethinyl estradiol and 4 capsules containing 75mg of ferrous fumarate (nonhormonal placebo).
There was high statewide variation observed for eclampsia, indicating that the median odds of eclampsia were higher if the same women delivered in a US state with higher vs lower eclampsia prevalence.